Cargando…
Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is a heterogeneous tumor that the underlying molecular mechanisms are largely unclear. This study aimed to elucidate the key candidate genes and pathways in ccRCC by integrated bioinformatics analysis. 1387 differentially expressed genes were identified based...
Autores principales: | Luo, Yongwen, Shen, Dexin, Chen, Liang, Wang, Gang, Liu, Xuefeng, Qian, Kaiyu, Xiao, Yu, Wang, Xinghuan, Ju, Lingao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738436/ https://www.ncbi.nlm.nih.gov/pubmed/31422942 http://dx.doi.org/10.18632/aging.102161 |
Ejemplares similares
-
Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020) -
The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
por: Chen, Siming, et al.
Publicado: (2021) -
PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis
por: Luo, Yongwen, et al.
Publicado: (2019) -
CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
por: Zhou, Fenfang, et al.
Publicado: (2021) -
Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023)